Emerging therapies for cartilage regeneration in currently excluded ‘red knee’ populations

Abstract

The field of articular cartilage repair has made significant advances in recent decades; yet current therapies are generally not evaluated or tested, at the time of pivotal trial, in patients with a variety of common comorbidities. To that end, we systematically reviewed cartilage repair clinical trials to identify common exclusion criteria and reviewed the literature to identify emerging regenerative approaches that are poised to overcome these current exclusion criteria. The term "knee cartilage repair" was searched on clinicaltrials.gov. Of the 60 trials identified on initial search, 33 were further examined to extract exclusion criteria. Criteria excluded by more than half of the trials were identified in order to focus discussion on emerging regenerative strategies that might address these concerns. These criteria included age (<18 or >55 years old), small defects (<1 cm 2), large defects (>8 cm 2), multiple defect (>2 lesions), BMI >35, meniscectomy (>50%), bilateral knee pathology, ligamentous instability, arthritis, malalignment, prior repair, kissing lesions, neurologic disease of lower extremities, inflammation, infection, endocrine or metabolic disease, drug or alcohol abuse, pregnancy, and history of cancer. Finally, we describe emerging tissue engineering and regenerative approaches that might foster cartilage repair in these challenging environments. The identified criteria exclude a majority of the affected population from treatment, and thus greater focus must be placed on these emerging cartilage regeneration techniques to treat patients with the challenging "red knee".

Development of biodegradable membranes for the delivery of a bioactive chitosan‐derivative on cartilage defects: A preliminary investigation

“…Among the conventional approaches for cartilage regeneration, autologous chondrocyte implantation (ACI), matrix‐induced autologous chondrocyte implantation (MACI), or autologous matrix‐induced chondrogenesis (AMIC) are the most used (Martín, Patel, Zlotnick, Carey, & Mauck, ). In ACI procedures, a section of healthy cartilage is harvested from patients.…”

Neural Crest-Derived Chondrocytes Isolation for Tissue Engineering in Regenerative Medicine

“…More recently proposed approaches for cartilage regeneration include matrix-associated autologous chondrocyte implantation (MACI) and autologous matrix-induced chondrogenesis (AMIC) [6].…”

“…x FOR PEER REVIEW 7 of Performance of ColG and ColH in cell release from cartilage using ColG and ColH in the presence of TML at different times(6,12, and 18 h).…”

Neuromedin B Promotes Chondrocyte Differentiation of Mesenchymal Stromal Cells via Calcineurin and Calcium Signaling

“…Common surgical treatments use chondroplasty, microfracture and mosaicplasty while more modern cartilage repair strategies include matrix-assisted chondrocyte implantation or autologous matrix-induced chondrogenesis [1]. Cartilage engineering approaches based on mesenchymal stromal/stem cells (MSCs) have provided promising results in pre-clinical models when MSCs are used in combination with scaffolds and differentiation factors such as transforming growth factor β (TGFβ) [2]. Yet, cartilage repair procedures may be disappointing on the longer term and lead to a non-functional brous or hypertrophic cartilage tissue.…”